Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 29 | ICEECE2012 | Next issue

15th International & 14th European Congress of Endocrinology

Poster Presentations

Bone & Osteoporosis

Previous section
Adrenal medulla
Table of contents
Next section
Calcium & Vitamin D metabolism

ea0029p129 | Bone & Osteoporosis

Unilateral and bilateral adrenal incidentaloma: comparing clinical and biochemical features

ea0029p130 | Bone & Osteoporosis

Bone mineral density is associated with BsmI vitamin D receptor’s polymorphism in adult patients with epilepsy

ea0029p131 | Bone & Osteoporosis

Vitamin D and estrogen receptors’ polymorphisms in postmenopausal women

ea0029p132 | Bone & Osteoporosis

Osteoporosis and vitamin D deficiency in patients with lipid storage disease

ea0029p133 | Bone & Osteoporosis

De novo autoimmune hepatitis associated with PTH(1–34) and PTH(1–84) administration for severe osteoporosis in a liver transplant patient

ea0029p134 | Bone & Osteoporosis

Osteogenesis imperfecta: phenotypic characteristics and response to treatment in an Irish cohort

ea0029p135 | Bone & Osteoporosis

Bone mineral density in diabetic postmenopausal women with bone fracture

ea0029p136 | Bone & Osteoporosis

Evidence for vitamin D deficiency and increased fractures’ prevalence in autoimmune bullous skin diseases

ea0029p137 | Bone & Osteoporosis

A correlation between bone mass density and body mass index and the lipid profile?

ea0029p138 | Bone & Osteoporosis

Vertebral fracture risk and bone metabolism in patients with addison’s disease

ea0029p139 | Bone & Osteoporosis

Bone mineral density and muscle mass in women with multiple sclerosis

ea0029p140 | Bone & Osteoporosis

Teriparatide: effects on cortical bone microstructure

ea0029p141 | Bone & Osteoporosis

Serum soluble RANKL levels are related to breast arterial calcification and hypertension in Japanese osteoporotic postmenopausal women

ea0029p142 | Bone & Osteoporosis

BMP-3b inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling

ea0029p143 | Bone & Osteoporosis

Glucocorticoid - treatment in the adrogenital syndrome due to deficit of 21-hydroxylase: long-term bone side effects

ea0029p144 | Bone & Osteoporosis

Polymorphism of the vitamin D3 receptor gene and bone mineral density in girls with functional hypothalamic amenorrhea subjected to estroprogestagen treatment

ea0029p145 | Bone & Osteoporosis

Altered bone mineral density in unilaterally orchiectomized subjects

ea0029p146 | Bone & Osteoporosis

Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria and recurring renal calcium lithiasis

ea0029p147 | Bone & Osteoporosis

Bone mineral density in patients with thalassaemia major in the UK

ea0029p148 | Bone & Osteoporosis

Abstract unavailable

ea0029p149 | Bone & Osteoporosis

Both high- and low levels of procollagen type 1 amino-terminal propeptide are associated with increased risk of hip fracture in elderly women. Norwegian Epidemiologic Osteoporosis Studies

ea0029p150 | Bone & Osteoporosis

Alendronate inhibits adipocyte differentiation in 3T3-L1 through a Vitamin D receptor mediated effect

ea0029p151 | Bone & Osteoporosis

Genetic predispositions do not explain short- and long-term effects of hormonal therapy on bone mineral density in girls with functional hypothalamic amenorrhea

ea0029p152 | Bone & Osteoporosis

Improved assessment of bone turnover by the PTH-(1–84)/ large C-PTH fragments ratio in dialysis patients

ea0029p153 | Bone & Osteoporosis

Comparaison of serum PTH concentrations obtained with a second and a third generation assay in a cohort of hemodialysis patients according to the KDIGO guidelines

ea0029p154 | Bone & Osteoporosis

Endoscopic comparison of esophageal and gastroduodenal mucosal effects of enterocoating alendronate with calcitriol combined drug and alendronate in Korean postmenopausal women

ea0029p155 | Bone & Osteoporosis

Functional hypoparathyroidism is a risk factor for bone fragility of postmenopausal women with vitamin D insufficiency

ea0029p156 | Bone & Osteoporosis

Platinum nanoparticle reduces ovariectomy-induced bone loss by decreasing osteoclastogenesis

ea0029p157 | Bone & Osteoporosis

The level of Osterix expression in osteoblasts is important to prevent IL6-induced inflammatory-prone state

ea0029p158 | Bone & Osteoporosis

Osteopenia/osteoporosis in patients with calcium nephrolithiasis

ea0029p159 | Bone & Osteoporosis

No effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy

ea0029p160 | Bone & Osteoporosis

Bone cross-sectional geometry and strength parameters at the radius by pQCT in male obese adolescents

ea0029p161 | Bone & Osteoporosis

Osteonecrosis of the jaw (ONJ) with superimposed osteomyelitis related to actinomyces in a patient with multiple myeloma receiving thalidomide and intravenous zoledronic acid

ea0029p162 | Bone & Osteoporosis

Effect of alcohol consumption on bone mineral density in healthy elderly Spanish males

ea0029p163 | Bone & Osteoporosis

Effect of alendronate on bone mineral density in primary hyperparathyroidism

ea0029p164 | Bone & Osteoporosis

Association of monocyte chemoatractant protein-1 and adiponectin with bone mineral density and osteocalcin in postmenopausal women

ea0029p165 | Bone & Osteoporosis

Age-dependent and sexual features of bone mineral density changes in rats with hyperthyroidism

ea0029p166 | Bone & Osteoporosis

Sinomaxillary myopericytoma associated with oncogenic osteomalacia

ea0029p167 | Bone & Osteoporosis

Body composition in postmenopausal women with vertebral fractures

ea0029p168 | Bone & Osteoporosis

Bone mineral density in relation to metabolic syndrome in postmenopausal women with diabetes type 2

ea0029p169 | Bone & Osteoporosis

Assessment of bone turnover and vitamin D levels in women with postmenopausal osteoporosis and type 2 diabetes mellitus

ea0029p170 | Bone & Osteoporosis

Osteoblast and adipocyte differentiation from human adipose tissue-derived cells

ea0029p171 | Bone & Osteoporosis

Denosumab increases BMD in primary hyperparathyroidism

ea0029p172 | Bone & Osteoporosis

Relationship between bone metabolism markers, bone mineral density and insulinresistance in healthy and diabetic postmenopausal women

ea0029p173 | Bone & Osteoporosis

The relation between quantitative characteristics of smoking and level of female skeleton damage

ea0029p174 | Bone & Osteoporosis

The assessment of the behavior of the interleukins IL1β and IL6 and bone mineral density (BMD) and bone metabolism (IBM) in women of postmenopausal age

ea0029p175 | Bone & Osteoporosis

Correction of bone mineral density losing in female rats with exogenous thyrotoxicosis with calcium and alendronate preparations

ea0029p176 | Bone & Osteoporosis

Reference intervals for serum N-MID osteocalcin concentration measured with the IDS-iSYS automated system

ea0029p177 | Bone & Osteoporosis

Prevalence of morphometric vertebral fractures and bone quality measured by spinal deformity index in type 1 diabetic patients

ea0029p178 | Bone & Osteoporosis

Clinical evaluation of a new specific 1–84 PTH automated platform

ea0029p179 | Bone & Osteoporosis

Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels

ea0029p180 | Bone & Osteoporosis

Investigating recurrent hypophostaemia

ea0029p181 | Bone & Osteoporosis

Ovariectomy modulates the effect of phytoestrogens on creatine kinase specific activity in skeletal organs in female rats

ea0029p182 | Bone & Osteoporosis

Bone turnover markers in medicamentous and physiological hyperprolactinemia in female rats

ea0029p183 | Bone & Osteoporosis

Adiponectin and bone mineral density in obese postmenopausal women

ea0029p184 | Bone & Osteoporosis

The body mass index and heel quantitative ultrasound analyze in 300 women

ea0029p185 | Bone & Osteoporosis

Cimetidine (histamine H2-receptor antagonist and antiandrogenic drug) exerts a beneficial effect in the injured tissues by periodontal disease in male rat molars

ea0029p186 | Bone & Osteoporosis

Age-dependent and sexual features of bone mineral density changes in rats in remote terms after hyperthyroidism abolition

ea0029p187 | Bone & Osteoporosis

Features of bone mineral density losing in ukranian woman of different ages with thyrotoxicosis

ea0029p188 | Bone & Osteoporosis

Comparison of the effects of hormone replacement therapy on bone mineral density, lipid profiles, and biochemical markers of bone metabolism

ea0029p189 | Bone & Osteoporosis

Bone mass in diabetic patients measured by lumbar spine and hip densitometry

ea0029p190 | Bone & Osteoporosis

Efficacy, safety and adherence to treatment of teriparatide: an observational study

ea0029p191 | Bone & Osteoporosis

Thyroxin treatment of multinodular and normofunctional goiter and bone mass.

ea0029p192 | Bone & Osteoporosis

Vitamin D status in patients treated with intravenous ibandronate: a cohort study

ea0029p193 | Bone & Osteoporosis

Correlations between the bone matrix markers and bone mineral density in postmenopausal osteoporosis

ea0029p194 | Bone & Osteoporosis

Zoledronic acid treatment improve bone strenght parameters assessed by BMD

ea0029p195 | Bone & Osteoporosis

Therapeutical management in hypogonadal osteoporosis

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more